This approach prioritises long-term treatment success over rapid escalation
However, some studies have shown that a decrease in blood sugar levels can occur as early as two weeks after starting treatment
The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors
Disruption of circadian rhythms contributes to obesity, metabolic disease and cancer, yet how the clock maintains metabolic homeostasis remains limited
Monitoring Your Treatment and Long-Term Management Initial monitoring: After starting B12 injections, your GP will typically arrange a full blood count (FBC) to assess haematological response
This is a single-use device containing one pre-set 7.2 mg dose, with a built-in hidden needle no needle changes are required